Veryan Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 46
Employees
  • Latest Deal Type
  • M&A

Veryan General Information

Description

Developer of a vascular biomimetic stent technology designed to improve the performance of vascular stents using the principles of biomimicry. The company's technology has a unique three-dimensional helical geometry, designed to impart natural curvature to the diseased artery, promoting secondary (swirling) flow and elevated wall shear stress, which has a protective effect on the endothelium to transform the treatment of patients with symptomatic peripheral arterial disease of the lower limbs, enabling patients to start treatment more quickly, resulting in a better medical outcome.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Parent Company
Otsuka Medical Devices
Primary Office
  • 15 City Business Centre
  • Brighton Road
  • Horsham RH13 5BB
  • England, United Kingdom
+44 01403 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Veryan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 13-Dec-2018 000.00 Completed Generating Revenue
8. Later Stage VC 06-Feb-2017 000.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 14-Jan-2015 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 26-Oct-2011 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 11-Mar-2010 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 02-Apr-2009 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 03-Aug-2007 00.000 0000 Completed Startup
2. Early Stage VC 11-May-2007 $6.18M $10.8M Completed Startup
1. Early Stage VC 10-Jan-2006 $4.63M $4.63M Completed Startup
To view Veryan’s complete valuation and funding history, request access »

Veryan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a vascular biomimetic stent technology designed to improve the performance of vascular stents using the pri
Surgical Devices
Horsham, United Kingdom
46 As of 2021
000.00
000000&0 000.00

000000 0

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
00000000 0000000
Wayne, PA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00 00000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
00000000 0000000
Milpitas, CA
00 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Veryan Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vesper Medical Venture Capital-Backed Wayne, PA 00 000.00 00000000000 000.00
00 000000 Formerly VC-backed Milpitas, CA 00 00000 000000&0 00000
00000000 Formerly VC-backed Herzlia, Israel 00 0000 000000&0 0000
0000 000000 0000 Venture Capital-Backed Plymouth, MN 00 000.00 0000000000 0 000.00
000000000 0000000 Formerly VC-backed Santa Clara, CA 000 00000 000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Veryan Executive Team (6)

Name Title Board Seat Contact Info
Chas Taylor Chief Executive Officer, Board Member & Executive Director
Nick Yeo Chief Operating Officer
Vanessa Lee Proctor and Case Support Manager
Paul Gilson Chief Scientific Officer, Executive Director & Board Member
You’re viewing 4 of 6 executive team members. Get the full list »

Veryan Board Members (8)

Name Representing Role Since
Chas Taylor Veryan Chief Executive Officer, Board Member & Executive Director 000 0000
Jeffrey Jump Self Board Member 000 0000
Paul Gilson Self Chief Scientific Officer, Executive Director & Board Member 000 0000
You’re viewing 3 of 8 board members. Get the full list »

Veryan Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Veryan Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Geoffrey Vernon Angel (individual) Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Invesco Asset Manager Minority 000 0000 000000 0
NPI Ventures Venture Capital Minority 000 0000 000000 0
Nesta Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »